Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | TARDBP | Q13148 | 2/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | THRB | P10828 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | ACHE | P22303 | 1/20 | 0.66 |
| ▸ | APEX1 | P27695 | 1/20 | 0.66 |
| ▸ | RECQL | P46063 | 1/20 | 0.66 |
| ▸ | BLM | P54132 | 1/20 | 0.66 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.66 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.66 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12972713 | 1.00 | HSD17B10 (0.66) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL7840915 | 0.90 | ACHE (0.55) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL7841104 | 0.89 | CA12 (0.63) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL7842227 | 0.89 | CA12 (0.63) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL19479306 | 0.88 | TSHR (0.53) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL7843232 | 0.88 | PPARG (0.60) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL7841701 | 0.87 | CA12 (0.61) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL7841737 | 0.87 | ACHE (0.51) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL7845468 | 0.87 | RECQL (0.58) | HSD17B10KMT2ATARDBPCYP2C9MEN1 | |
| SCHEMBL24601927 | 0.87 | HSD17B10 (0.70) | HSD17B10KMT2ATARDBPCYP2C9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109824655-B | Andrographolide compound and preparation method and application thereof | 沈阳药科大学 | 2021-09-24 | — | — | CN | claimed |
| CN-104404098-A | Biological preparation method of lipoic acid | ENZYMEWORKS INC | 2015-03-11 | — | — | CN | claimed |
| CN-101549153-A | Composite and method for self-treating tumor | BAOFA YU (CN) | 2009-10-07 | — | — | CN | claimed |
| CN-1273146-C | Composition for treating tumor | YU BAOFA (US) | 2006-09-06 | — | — | CN | claimed |
| CN-1431909-A | Combinations for treating neoplasms | YU BAOFA (US) | 2003-07-23 | — | — | CN | claimed |
| US-12043865-B2 | Genetic probe for the detection of a single nucleotide polymorphism (SNP) or a single nucleotide modification of a target nucleic acid | THE UNIVERSITY OF BIRMINGHAM (GB) | 2024-07-23 | — | — | US | disclosed |
| WO-2024134266-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF DERMAL AND OCULAR DISORDERS | Azura Ophthalmics Ltd. (IL) | 2024-06-27 | — | — | WO | disclosed |
| US-20230346744-A1 | SULFUR-CONTAINING COMPOUND USEFUL FOR TREATING OR PREVENTING PRESBYOPIA | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2023-11-02 | — | — | US | disclosed |
| US-20230346744-A1 | SULFUR-CONTAINING COMPOUND USEFUL FOR TREATING OR PREVENTING PRESBYOPIA | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2023-11-02 | — | — | US | disclosed |
| US-20230346744-A1 | SULFUR-CONTAINING COMPOUND USEFUL FOR TREATING OR PREVENTING PRESBYOPIA | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2023-11-02 | — | — | US | disclosed |
| EP-4159209-A1 | SULFUR-CONTAINING COMPOUND USEFUL FOR TREATING OR PREVENTING PRESBYOPIA | Santen Pharmaceutical Co., Ltd. (JP) | 2023-04-05 | — | — | EP | disclosed |
| CN-115515570-A | Sulfur-containing compounds useful for the treatment or prevention of presbyopia | 参天制药株式会社 | 2022-12-23 | — | — | CN | disclosed |
| US-7615775-B2 | Semiconductor apparatus and process for fabricating same | SONY CORPORATION (JP) | 2009-11-10 | — | — | US | disclosed |
| US-7615775-B2 | Semiconductor apparatus and process for fabricating same | SONY CORPORATION (JP) | 2009-11-10 | — | — | US | disclosed |
| CN-101549153-A | Composite and method for self-treating tumor | BAOFA YU (CN) | 2009-10-07 | — | — | CN | disclosed |
| CN-1273146-C | Composition for treating tumor | YU BAOFA (US) | 2006-09-06 | — | — | CN | disclosed |
| CN-1680364-A | Method for producing lipoic acid and dihydrolipoic acid | BASF AG (DE) | 2005-10-12 | — | — | CN | disclosed |
| CN-1218945-C | Preparation method of lipoic acid and dihydrolipoic acid | BASF AG (DE) | 2005-09-14 | — | — | CN | disclosed |
| CN-1444580-A | Preparation method of lipoic acid and dihydrolipoic acid | BASF AG (DE) | 2003-09-24 | — | — | CN | disclosed |
| CN-1431909-A | Combinations for treating neoplasms | YU BAOFA (US) | 2003-07-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230346744-A1 | SULFUR-CONTAINING COMPOUND USEFUL FOR TREATING OR PREVENTING PRESBYOPIA | CBS, PSEN1, PSEN2 | HSD17B10 1875/4885KMT2A 3172/4885TARDBP 1808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.